Core Viewpoint - The company reported a decline in revenue and a net loss for the fiscal year 2025, attributing the results to delays in the execution of key projects, which impacted revenue recognition and delivery timelines [1]. Financial Performance - The company achieved an operating revenue of 146 million yuan, representing a year-on-year decrease of 4.29% [1]. - The net loss attributable to the parent company's shareholders was 63.76 million yuan, with a basic loss per share of 0.62 yuan [1]. Strategic Focus - During the reporting period, the company concentrated on its core strategy and coordinated various business operations [1]. - The delays in the execution of important projects were highlighted as a significant factor affecting the company's financial performance [1].
兴图新科(688081.SH)2025年度归母净亏损6376.55万元